Taysha Gene Therapies Inc reports results for the quarter ended in March - Earnings Summary

Taysha Gene Therapies

16/05/2022 14:32

* Taysha Gene Therapies Inc  TSHA.OQ  reported a quarterly
adjusted loss of $1.31​​ per share for the quarter ended in
March. The mean expectation of fifteen analysts for the quarter
was for a loss of $1.07 per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Taysha Gene Therapies Inc's reported EPS for the quarter
was a
loss of $1.31​.
    * The mean earnings estimate of analysts had risen by
about 15.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Taysha Gene Therapies Inc shares had fallen by 47.2% this
quarter and lost 70.5% so far this year.
    * The company reported a quarterly loss of $50.11 million.
    * Wall Street's median 12-month price target for Taysha Gene
Therapies Inc is $27.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated